Brendan Smith
Stock Analyst at TD Cowen
(4.27)
# 1,342
Out of 4,377 analysts
260
Total ratings
48.2%
Success rate
10.5%
Average return
Main Sectors:
Stocks Rated by Brendan Smith
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RPID Rapid Micro Biosystems | Maintained: Buy | n/a | $1.99 | - | 7 | May 27, 2026 | |
| TWST Twist Bioscience | Reiterated: Buy | $68 | $69.22 | -1.76% | 16 | May 22, 2026 | |
| MXCT MaxCyte | Maintained: Buy | n/a | $1.14 | - | 11 | May 12, 2026 | |
| PASG Passage Bio | Reiterated: Hold | n/a | $5.62 | - | 10 | May 12, 2026 | |
| HALO Halozyme Therapeutics | Maintained: Buy | $96 | $71.53 | +34.21% | 23 | May 11, 2026 | |
| CERT Certara | Rated: Buy | $10 → $9 | $5.37 | +67.60% | 9 | May 11, 2026 | |
| ABCL AbCellera Biologics | Maintained: Buy | n/a | $5.62 | - | 10 | May 11, 2026 | |
| CDXS Codexis | Maintained: Hold | $2 | $2.56 | -21.88% | 10 | May 7, 2026 | |
| BLFS BioLife Solutions | Maintained: Buy | $33 | $26.65 | +23.83% | 11 | May 7, 2026 | |
| DNA Ginkgo Bioworks Holdings | Maintained: Buy | $12 | $8.22 | +45.99% | 13 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $6.40 | - | 9 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $4.09 | +22.25% | 11 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $2.48 | +20.97% | 10 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $30 → $20 | $22.69 | -11.86% | 11 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $2.80 | +42.86% | 9 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.93 | - | 10 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.32 | - | 10 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $4.56 | +53.51% | 11 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $200 | $122.31 | +63.52% | 10 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $14.38 | +39.08% | 11 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $350 → $365 | $314.50 | +16.06% | 5 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 → $16 | $15.88 | +0.76% | 4 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $73.09 | n/a | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $19.52 | n/a | 11 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $9 | $9.49 | n/a | 6 | Nov 12, 2024 |
Rapid Micro Biosystems
May 27, 2026
Maintained: Buy
Price Target: n/a
Current: $1.99
Upside: -
Twist Bioscience
May 22, 2026
Reiterated: Buy
Price Target: $68
Current: $69.22
Upside: -1.76%
MaxCyte
May 12, 2026
Maintained: Buy
Price Target: n/a
Current: $1.14
Upside: -
Passage Bio
May 12, 2026
Reiterated: Hold
Price Target: n/a
Current: $5.62
Upside: -
Halozyme Therapeutics
May 11, 2026
Maintained: Buy
Price Target: $96
Current: $71.53
Upside: +34.21%
Certara
May 11, 2026
Rated: Buy
Price Target: $10 → $9
Current: $5.37
Upside: +67.60%
AbCellera Biologics
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $5.62
Upside: -
Codexis
May 7, 2026
Maintained: Hold
Price Target: $2
Current: $2.56
Upside: -21.88%
BioLife Solutions
May 7, 2026
Maintained: Buy
Price Target: $33
Current: $26.65
Upside: +23.83%
Ginkgo Bioworks Holdings
May 7, 2026
Maintained: Buy
Price Target: $12
Current: $8.22
Upside: +45.99%
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $6.40
Upside: -
May 7, 2026
Maintained: Hold
Price Target: $5
Current: $4.09
Upside: +22.25%
May 7, 2026
Maintained: Buy
Price Target: $3
Current: $2.48
Upside: +20.97%
May 6, 2026
Maintained: Hold
Price Target: $30 → $20
Current: $22.69
Upside: -11.86%
May 6, 2026
Maintained: Buy
Price Target: $4
Current: $2.80
Upside: +42.86%
May 6, 2026
Maintained: Buy
Price Target: n/a
Current: $7.93
Upside: -
May 6, 2026
Maintained: Hold
Price Target: n/a
Current: $3.32
Upside: -
May 6, 2026
Reiterated: Buy
Price Target: $7
Current: $4.56
Upside: +53.51%
May 5, 2026
Maintained: Buy
Price Target: $200
Current: $122.31
Upside: +63.52%
May 5, 2026
Maintained: Buy
Price Target: $20
Current: $14.38
Upside: +39.08%
Apr 23, 2026
Rated: Buy
Price Target: $350 → $365
Current: $314.50
Upside: +16.06%
Apr 9, 2026
Reiterated: Hold
Price Target: $19 → $16
Current: $15.88
Upside: +0.76%
May 13, 2025
Maintained: Buy
Price Target: n/a
Current: $73.09
Upside: n/a
May 6, 2025
Maintained: Buy
Price Target: n/a
Current: $19.52
Upside: n/a
Nov 12, 2024
Maintained: Hold
Price Target: $14 → $9
Current: $9.49
Upside: n/a